sever
acut
respiratori
syndromecoronaviru
nonstructur
sarscov
main
transcriptas
sar
cleav
polyprotein
kda
kda
infect
human
embryo
lung
cellular
protein
interact
sarscov
hepi
novel
gene
previous
isol
cdna
librari
human
embryon
lung
tissu
protein
encod
interact
sarscov
hepi
gene
express
two
differ
isoform
isoform
isoform
b
amino
acid
long
respect
previous
demonstr
hepi
differenti
express
ten
differ
type
cancer
includ
stomach
liver
prostat
cancer
furthermor
transcript
factor
cjun
associ
transcript
regul
hepi
gene
breast
cancer
one
common
malign
affect
women
worldwid
incid
per
women
western
europ
breast
cancer
progress
complex
process
compris
cell
cycl
dysregul
metastasi
distant
organ
varieti
steroid
hormon
estrogen
progesteron
express
specif
gene
zinc
finger
eboxbind
homeobox
matrix
metallopeptidas
attribut
growth
metastasi
breast
cancer
cell
previou
studi
show
transcript
factor
zinc
finger
eboxbind
homeobox
regul
express
gene
promot
breast
cancer
cell
prolifer
bone
morphogenet
protein
found
inhibit
breast
cancer
cell
prolifer
target
direct
target
rb
transcript
corepressor
clinic
therapeut
intervent
growth
metastasi
breast
cancer
remain
limit
previou
studi
demonstr
express
hepi
significantli
higher
compar
cell
howev
function
hepi
breast
cancer
cell
prolifer
yet
elucid
elucid
mechan
may
provid
novel
approach
therapi
order
reveal
role
hepi
develop
breast
cancer
function
hepi
cell
prolifer
regul
gene
hepi
investig
present
studi
result
may
provid
basi
establish
effect
treatment
strategi
breast
cancer
fulllength
hepi
isoform
b
code
sequenc
cd
amplifi
cdna
use
pcr
follow
primer
forward
revers
pcr
fragment
run
agaros
gel
photograph
recov
digest
hindiii
aagctt
bamhi
ggatcc
clone
vector
bd
bioscienc
plasmid
contain
cd
sequenc
hepi
isoform
wherea
plasmid
contain
cd
sequenc
hepi
isoform
b
partial
human
hepi
cd
amplifi
cdna
use
pcr
follow
primer
forward
revers
pcr
fragment
clone
promega
corpor
vector
use
xhoi
ctcgag
noti
gcggccgc
restrict
site
partial
human
hepi
cd
sequenc
contain
target
site
small
interf
si
rna
describ
target
sirna
sequenc
human
hepi
oligonucleotid
anneal
ligat
psilenc
ambion
thermo
fisher
scientif
inc
construct
hepisspecif
sirna
express
plasmid
respect
accord
manufactur
protocol
psilenc
express
scrambl
sirna
ambion
thermo
fisher
scientif
inc
use
sicontrol
hela
cell
atcc
maintain
high
glucos
dmem
gibco
thermo
fisher
scientif
inc
supplement
fetal
bovin
serum
fb
hyclon
ge
healthcar
life
scienc
penicillin
uml
streptomycin
uml
incub
hela
cell
transfect
plasmid
use
thermo
fisher
scientif
inc
accord
manufactur
protocol
hela
cell
seed
densiti
cellswel
plate
h
cultur
cell
transfect
ngwell
subcellular
local
hela
cell
seed
densiti
cellswel
plate
h
cultur
cell
transfect
ngwell
plasmid
revers
transcriptionquantit
pcr
rtqpcr
cell
seed
densiti
cellswel
plate
h
cultur
cell
cotransfect
ngwell
either
sicontrol
ngwell
silenc
target
site
select
cell
transfect
ngwell
sicontrol
cell
count
assay
cell
cotransfect
ngwell
sicontrol
ngwell
ngwell
prltk
dualluciferas
report
dlr
assay
cell
seed
densiti
cellswel
plate
h
cultur
cell
transfect
ngwell
sicontrol
plasmid
edu
cell
prolifer
assay
rtqpcr
cell
transfect
ngwell
either
western
blot
cell
transfect
ngwell
either
gene
chip
assay
transmembran
domain
hepi
predict
transmembran
hidden
markov
model
tmhmm
server
http
wwwcbsdtudkservicestmhmm
hela
cell
transfect
aforement
h
posttransfect
cell
stain
dapi
min
visual
invert
fluoresc
microscop
describ
previous
cell
transfect
aforement
h
posttransfect
western
blot
perform
describ
previous
primari
antibodi
specif
gfp
cat
santa
cruz
dilut
cat
abcam
dilut
secondari
antibodi
goat
antirabbit
igg
h
l
hrp
cat
abcam
dilut
use
cell
transfect
vector
aforement
h
cell
lyse
cell
lysat
assay
firefli
renilla
luciferas
activ
use
dualluciferas
report
assay
system
promega
corpor
accord
manufactur
protocol
renilla
luciferas
activ
normal
firefli
luciferas
activ
experi
perform
triplic
cell
transfect
aforement
h
cell
seed
plate
densiti
cellswel
six
replic
per
experi
assay
dojindo
molecular
technolog
inc
perform
day
transfect
describ
previous
edu
assay
cell
transfect
aforement
cell
incub
edu
h
h
transfect
cell
fix
paraformaldehyd
min
stain
mgml
hoechst
describ
previous
imag
captur
eduposit
cell
calcul
describ
previous
report
plasmid
pathdetect
agil
technolog
inc
contain
respons
element
gggaatttccgggaatttccgggaaccggattgaccggccatggcgatcgcccttaaaggcccttaaaggccctttttccgggaatttcc
clone
firefli
luciferas
therefor
use
measur
transcript
activ
intern
control
prltk
plasmid
contain
renilla
luciferas
gene
promega
corpor
cell
transfect
aforement
h
posttransfect
dlr
assay
perform
use
dualluciferas
report
assay
system
promega
corpor
accord
manufactur
protocol
firefli
luciferas
activ
normal
renilla
luciferas
activ
rna
microarray
contain
sampl
case
breast
cancer
match
adjac
normal
tissu
obtain
shanxi
chaoy
biotechnolog
co
ltd
cat
antisens
probe
sequenc
match
part
hepi
use
hybrid
perform
previous
describ
dapi
use
counterstain
stain
cell
visual
imag
captur
use
laser
scan
confoc
microscop
consist
excit
wavelength
among
group
result
stain
analyz
use
imagej
softwar
version
nation
institut
health
cell
transfect
aforement
h
transfect
rna
extract
use
trizol
cat
invitrogen
thermo
fisher
scientif
inc
purifi
use
rneasi
mini
kit
cat
rnasefre
dnase
set
cat
qiagen
gmbh
total
rna
amplifi
label
use
low
input
quick
amp
label
kit
onecolor
cat
agil
technolog
inc
accord
manufactur
protocol
label
complementari
rna
crna
purifi
use
rneasi
mini
kit
cat
qiagen
gmbh
previous
describ
slide
agil
sureprint
human
gene
express
microarray
hybrid
ng
crna
use
hybrid
kit
cat
wash
stain
dish
wash
buffer
kit
cat
agil
technolog
inc
h
hybrid
accord
manufactur
instruct
slide
scan
use
agil
microarray
scanner
cat
agil
technolog
inc
follow
default
set
dye
channel
green
scan
resolut
photomultipli
tube
color
depth
bit
data
extract
use
featur
extract
softwar
agil
technolog
inc
raw
data
normal
use
quantil
algorithm
limma
packag
r
version
http
wwwrprojectorg
two
sampl
use
gene
chip
assay
differenti
express
mrna
identifi
fold
chang
p
go
enrich
http
geneontologyorg
releas
number
kegg
pathway
http
wwwgenomejpkegg
releas
number
juli
analysi
differenti
express
mrna
perform
describ
previous
hela
cell
transfect
aforement
h
transfect
rna
extract
use
invitrogen
thermo
fisher
scientif
inc
purifi
use
rneasi
mini
kit
qiagen
gmbh
total
rna
sampl
use
firststrand
cdna
synthesi
use
mmlv
revers
transcript
kit
promega
corpor
accord
manufactur
protocol
specif
product
human
hepi
amplifi
use
qpcr
follow
primer
hepi
forward
revers
gapdh
forward
revers
gapdh
use
intern
control
cell
transfect
aforement
h
transfect
rna
extract
purif
revers
transcript
perform
aforement
specif
product
human
interleukin
receptor
subunit
interferon
receptor
subunit
gene
amplifi
use
qpcr
use
follow
primer
forward
revers
forward
revers
forward
revers
gapdh
use
intern
control
univers
pcr
max
mix
appli
biosystem
use
qpcr
accord
manufactur
protocol
qpcr
perform
use
follow
thermocycl
condit
sec
sec
sec
cycl
quantif
perform
use
method
describ
previous
data
present
mean
standard
deviat
spss
softwar
spss
inc
use
statist
analysi
data
rtqpcr
edu
cell
prolifer
assay
analyz
use
student
ttest
data
analyz
use
oneway
anova
follow
dunnett
post
hoc
test
optic
densiti
integr
optic
densiti
breast
cancer
normal
breast
tissu
analyz
use
student
ttest
p
consid
indic
statist
signific
differ
data
repres
three
independ
experi
hepi
exist
two
differ
isoform
b
pcr
perform
determin
express
level
b
isoform
cell
result
reveal
isoform
express
cell
isoform
abund
form
hepi
base
intens
band
fig
isoform
b
consist
amino
acid
respect
fig
predict
molecular
mass
kda
respect
protein
analys
tmhmm
reveal
hepi
protein
predict
transmembran
domain
suggest
may
solubl
protein
determin
subcellular
local
cdna
isoform
fuse
gfp
vector
transfect
hela
cell
overexpress
hepisa
hepisb
confirm
use
qpcr
fig
hepisagfp
hepisbgfp
fusion
protein
primarili
express
cytoplasm
hela
cell
fig
result
western
blot
analysi
reveal
express
hepisagfp
fusion
protein
plasmid
express
hepisbgfp
fusion
protein
cell
fig
previou
studi
report
hepi
differenti
express
breast
cancer
cell
line
present
studi
rna
situ
hybrid
perform
use
tissu
microarray
contain
breast
cancer
tissu
adjac
normal
tissu
case
studi
express
hepi
hepisposit
stain
primarili
found
cytoplasm
case
fig
integr
optic
densiti
hepi
significantli
lower
p
malign
breast
cancer
tissu
compar
adjac
normal
breast
tissu
tabl
previou
studi
report
hepi
reduc
prolifer
hela
cell
assess
effect
hepi
prolifer
breast
cancer
cell
cell
transfect
hepisexpress
plasmid
assay
perform
shown
fig
result
assay
indic
overexpress
isoform
hepi
cell
significantli
decreas
cell
prolifer
compar
cell
transfect
empti
vector
control
test
effect
knockdown
endogen
hepi
express
cell
prolifer
three
differ
sirna
plasmid
target
human
hepi
construct
abil
three
plasmid
inhibit
hepi
gene
express
use
dlr
assay
vector
perform
result
reveal
hepi
express
lowest
cell
transfect
fig
result
qpcr
analysi
show
overexpress
significantli
reduc
express
hepi
transcript
level
fig
shown
fig
knockdown
hepi
significantli
increas
number
cell
compar
control
confirm
hepi
growthinhibit
effect
cell
furthermor
result
edu
prolifer
assay
reveal
overexpress
isoform
hepi
decreas
number
cell
phase
hepisa
hepisb
fig
contrast
hepi
knockdown
result
mark
increas
number
cell
phase
show
increas
fig
base
result
confirm
hepi
inhibit
cell
prolifer
dlr
assay
perform
identifi
potenti
cellular
pathway
regul
hepi
reveal
two
isoform
hepi
overexpress
significantli
inhibit
nfkb
report
gene
cell
compar
control
group
fig
contrast
hepi
knockdown
result
signific
increas
report
gene
activ
fig
understand
molecular
chang
follow
hepi
overexpress
gene
chip
analysi
perform
identifi
mrna
differenti
express
hepisoverexpress
cell
control
cell
result
gene
chip
assay
show
gene
differenti
express
hepisoverexpress
cell
includ
gene
upregul
downregul
fig
differenti
express
gene
analyz
use
go
enrich
kegg
pathway
analysi
top
signific
enrich
pathway
go
enrich
analysi
includ
transmembran
receptor
protein
serinethreonin
kinas
activ
regul
cell
toler
induct
among
other
tabl
ii
top
signific
enrich
pathway
kegg
pathway
list
tabl
iii
includ
mitogenactiv
protein
kinas
mapk
signal
pathway
janu
kinasesign
transduc
activ
transcript
jakstat
signal
pathway
focal
adhes
other
gene
select
qpcr
analysi
enrich
jakstat
signal
pathway
kegg
enrich
analysi
qpcr
result
confirm
mrna
level
three
gene
downregul
hepisoverexpress
cell
compar
group
h
posttransfect
fig
previous
hepi
isoform
b
identifi
amino
acid
long
protein
sever
casein
kinas
ii
phosphoryl
site
present
studi
hepi
isoform
b
found
express
cell
isoform
abundantli
express
isoform
similar
present
studi
previou
studi
also
show
overexpress
hepi
isoform
b
reduc
prolifer
hela
cell
present
studi
demonstr
overexpress
hepi
isoform
significantli
inhibit
cell
cycl
progress
breast
cancer
cell
inhibit
transit
rna
interfer
target
hepi
exhibit
result
increas
cell
cycl
progress
confirm
potenti
role
hepi
regul
cell
prolifer
group
previous
report
hepi
express
significantli
increas
four
breast
cancer
cell
line
addit
hepi
express
level
higher
cell
line
compar
cell
line
cell
prolifer
complex
process
regul
multipl
gene
cmyc
cyclin
differ
express
hepi
gene
complet
determin
growth
rate
cell
hepi
esophag
squamou
cell
carcinoma
exhibit
upregul
express
compar
adjac
normal
tissu
wherea
rectal
adenocarcinoma
revers
observ
therefor
hepi
may
possess
vari
function
differ
type
cancer
due
cancer
complex
mechan
present
studi
hepi
express
downregul
breast
cancer
tissu
compar
adjac
normal
tissu
belong
member
famili
hetero
homodimer
transcript
factor
serv
vital
role
cell
prolifer
apoptosi
result
present
studi
demonstr
hepi
inhibit
activ
report
gene
hepi
may
serv
import
role
regul
signal
pathway
jakstat
signal
pathway
transmit
inform
extracellular
signal
includ
wide
array
cytokin
etc
growth
factor
epiderm
growth
factor
plateletderiv
growth
factor
etc
pathway
play
role
prolifer
migrat
apoptosi
disrupt
dysregul
pathway
result
prostat
cancer
breast
cancer
mapk
highli
conserv
famili
serinethreonin
protein
kinas
involv
differ
cellular
process
prolifer
surviv
apoptosi
differenti
motil
develop
erk
jnkstressactiv
protein
kinas
three
major
mapk
famili
serv
import
role
tumor
progress
breast
cancer
kegg
pathway
analysi
show
differenti
express
gene
regul
hepi
function
enrich
mapk
jakstat
signal
pathway
therefor
hepi
may
regul
progress
breast
cancer
influenc
mapk
jakstat
signal
pathway
receptor
pathway
involv
regul
carcinoma
cell
prolifer
endogen
promot
growth
protect
tumor
cell
apoptosi
lead
phosphoryl
jakstat
gene
induct
well
antivir
antiprolif
cellular
respons
present
studi
qpcr
result
reveal
downregul
hepi
therefor
hepi
may
inhibit
cell
prolifer
regul
conclus
result
show
hepi
primarili
express
cytoplasm
cell
inhibit
activ
report
gene
furthermor
novel
function
hepi
reveal
prolifer
inhibitor
breast
cancer
progress
result
gene
chip
analysi
reveal
gene
differenti
express
hepi
overexpress
group
gene
enrich
mapk
jakstat
signal
pathway
differenti
express
gene
confirm
use
qpcr
togeth
hepi
may
repres
novel
target
molecul
repress
breast
cancer
progress
